Literature DB >> 20590633

Chemo-nociceptive signalling from the colon is enhanced by mild colitis and blocked by inhibition of transient receptor potential ankyrin 1 channels.

Martina Mitrovic1, Anaid Shahbazian, Elisabeth Bock, Maria A Pabst, Peter Holzer.   

Abstract

BACKGROUND AND
PURPOSE: Transient receptor potential ankyrin 1 (TRPA1) channels are expressed by primary afferent neurones and activated by irritant chemicals including allyl isothiocyanate (AITC). Here we investigated whether intracolonic AITC causes afferent input to the spinal cord and whether this response is modified by mild colitis, morphine or a TRPA1 channel blocker. EXPERIMENTAL APPROACH: One hour after intracolonic administration of AITC to female mice, afferent signalling was visualized by expression of c-Fos in laminae I-II(o) of the spinal dorsal horn at sacral segment S1. Mild colitis was induced by dextran sulphate sodium (DSS) added to drinking water for 1 week. KEY
RESULTS: Relative to vehicle, AITC (2%) increased expression of c-Fos in the spinal cord. Following induction of mild colitis by DSS (2%), spinal c-Fos responses to AITC, but not vehicle, were augmented by 41%. Colonic inflammation was present (increased myeloperoxidase content and disease activity score), whereas colonic histology, locomotion, feeding and drinking remained unchanged. Morphine (10 mg.kg(-1)) or the TRPA1 channel blocker HC-030031 (300 mg.kg(-1)) inhibited the spinal c-Fos response to AITC, in control and DSS-pretreated animals, whereas the response to intracolonic capsaicin (5%) was blocked by morphine but not HC-030031. CONCLUSIONS AND IMPLICATIONS: Activation of colonic TRPA1 channels is signalled to the spinal cord. Mild colitis enhanced this afferent input that, as it is sensitive to morphine, is most likely of a chemonociceptive nature. As several irritant chemicals can be present in chyme, TRPA1 channels may mediate several gastrointestinal pain conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20590633      PMCID: PMC2938814          DOI: 10.1111/j.1476-5381.2010.00794.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  63 in total

1.  A new model of visceral pain and referred hyperalgesia in the mouse.

Authors:  J M A Laird; L Martinez-Caro; E Garcia-Nicas; F Cervero
Journal:  Pain       Date:  2001-06       Impact factor: 6.961

Review 2.  Sensory transmission in the gastrointestinal tract.

Authors:  L A Blackshaw; S J H Brookes; D Grundy; M Schemann
Journal:  Neurogastroenterol Motil       Date:  2007-01       Impact factor: 3.598

3.  Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium.

Authors:  Edward S Kimball; Craig R Schneider; Nathaniel H Wallace; Pamela J Hornby
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-03-30       Impact factor: 4.052

4.  Morphine or U-50,488 suppresses Fos protein-like immunoreactivity in the spinal cord and nucleus tractus solitarii evoked by a noxious visceral stimulus in the rat.

Authors:  D L Hammond; R Presley; K R Gogas; A I Basbaum
Journal:  J Comp Neurol       Date:  1992-01-08       Impact factor: 3.215

5.  Transient receptor potential ankyrin-1 participates in visceral hyperalgesia following experimental colitis.

Authors:  Jing Yang; Yanqing Li; Xiuli Zuo; Yanbo Zhen; Yanbo Yu; Lijun Gao
Journal:  Neurosci Lett       Date:  2008-06-24       Impact factor: 3.046

6.  Transient receptor potential ankyrin receptor 1 is a novel target for pro-tussive agents.

Authors:  E Andrè; R Gatti; M Trevisani; D Preti; P G Baraldi; R Patacchini; P Geppetti
Journal:  Br J Pharmacol       Date:  2009-10-20       Impact factor: 8.739

7.  Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.

Authors:  J E Krawisz; P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-12       Impact factor: 22.682

8.  TRPA1 in mast cell activation-induced long-lasting mechanical hypersensitivity of vagal afferent C-fibers in guinea pig esophagus.

Authors:  Shaoyong Yu; Guofeng Gao; Blaise Z Peterson; Ann Ouyang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-05-07       Impact factor: 4.052

9.  Endogenous neuropeptide Y depresses the afferent signaling of gastric acid challenge to the mouse brainstem via neuropeptide Y type Y2 and Y4 receptors.

Authors:  T Wultsch; E Painsipp; C K Thoeringer; H Herzog; G Sperk; P Holzer
Journal:  Neuroscience       Date:  2005-10-10       Impact factor: 3.590

10.  The ion channel TRPA1 is required for normal mechanosensation and is modulated by algesic stimuli.

Authors:  Stuart M Brierley; Patrick A Hughes; Amanda J Page; Kelvin Y Kwan; Christopher M Martin; Tracey A O'Donnell; Nicole J Cooper; Andrea M Harrington; Birgit Adam; Tobias Liebregts; Gerald Holtmann; David P Corey; Grigori Y Rychkov; L Ashley Blackshaw
Journal:  Gastroenterology       Date:  2009-07-24       Impact factor: 22.682

View more
  26 in total

1.  Modulation of mouse gastrointestinal motility by allyl isothiocyanate, a constituent of cruciferous vegetables (Brassicaceae): evidence for TRPA1-independent effects.

Authors:  Raffaele Capasso; Gabriella Aviello; Barbara Romano; Francesca Borrelli; Luciano De Petrocellis; Vincenzo Di Marzo; Angelo A Izzo
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice.

Authors:  Angelo A Izzo; Raffaele Capasso; Gabriella Aviello; Francesca Borrelli; Barbara Romano; Fabiana Piscitelli; Laura Gallo; Francesco Capasso; Pierangelo Orlando; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 3.  Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system.

Authors:  Peter Holzer
Journal:  Pharmacol Ther       Date:  2011-03-21       Impact factor: 12.310

Review 4.  Sensory neuron regulation of gastrointestinal inflammation and bacterial host defence.

Authors:  N Y Lai; K Mills; I M Chiu
Journal:  J Intern Med       Date:  2017-02-02       Impact factor: 8.989

5.  Gut Inflammation Induced by Dextran Sulfate Sodium Exacerbates Amyloid-β Plaque Deposition in the AppNL-G-F Mouse Model of Alzheimer's Disease.

Authors:  Mona Sohrabi; Heidi L Pecoraro; Colin K Combs
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

6.  Activation of TRPA1 on dural afferents: a potential mechanism of headache pain.

Authors:  Rebecca M Edelmayer; Larry N Le; Jin Yan; Xiaomei Wei; Romina Nassini; Serena Materazzi; Delia Preti; Giovanni Appendino; Pierangelo Geppetti; David W Dodick; Todd W Vanderah; Frank Porreca; Gregory Dussor
Journal:  Pain       Date:  2012-07-17       Impact factor: 6.961

Review 7.  Animal models of inflammatory bowel disease: a review.

Authors:  Nidhi Goyal; Ajay Rana; Abhilasha Ahlawat; Krishna Reddy V Bijjem; Puneet Kumar
Journal:  Inflammopharmacology       Date:  2014-06-07       Impact factor: 4.473

8.  Epithelial transient receptor potential ankyrin 1 (TRPA1)-dependent adrenomedullin upregulates blood flow in rat small intestine.

Authors:  Toru Kono; Atsushi Kaneko; Yuji Omiya; Katsuya Ohbuchi; Nagisa Ohno; Masahiro Yamamoto
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-12-28       Impact factor: 4.052

Review 9.  Regulation of Pain and Itch by TRP Channels.

Authors:  Carlene Moore; Rupali Gupta; Sven-Eric Jordt; Yong Chen; Wolfgang B Liedtke
Journal:  Neurosci Bull       Date:  2017-12-27       Impact factor: 5.203

10.  TRPM8 activation attenuates inflammatory responses in mouse models of colitis.

Authors:  Rithwik Ramachandran; Eric Hyun; Liena Zhao; Tamia K Lapointe; Kevin Chapman; Christina L Hirota; Subrata Ghosh; David D McKemy; Nathalie Vergnolle; Paul L Beck; Christophe Altier; Morley D Hollenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.